"V体育平台登录" Ren Lab
Dr. Ren leads the research and operational activities of the NYGC, which focus on the development of computational and experimental genomic methods and disease-focused research to better understand the genetic basis of cancer, neurodegenerative diseases, and neuropsychiatric diseases VSports app下载. He also directs NYGC’s faculty, who lead independent research labs based at the Center. A pioneer in epigenomics, Dr. Bing Ren has made foundational discoveries in gene regulation, including mapping millions of regulatory elements, uncovering chromatin organization principles, and interpreting non-coding disease variants.
Bing Ren, PhD
Scientific Director and CEO, NYGC
Professor of Genetics and Development, Biochemistry and Molecular Biophysics, and Systems Biology, Associate Director in the Vagelos Institute for Basic Biomedical Science (Vagelos Institute) in VP&S, Columbia University
Latest News & Publications
-
Genome Research · October 1, 2025
-
bioRxiv · September 29, 2025 · Preprint
Brain Region-Specific Epigenomic Reorganization and Altered Cell States in Alzheimer’s Disease.
-
V体育平台登录 - ArXiv · August 21, 2025 · Preprint
FAIR sharing of Chromatin Tracing datasets using the newly developed 4DN FISH Omics Format.
Highlights from Dr. Ren's Previous Work
-
Science · 2023 October 13.
A comparative atlas of single-cell chromatin accessibility in the human brain.
-
Cell · 2021 November 24.
"VSports手机版" A single-cell atlas of chromatin accessibility in the human genome.
-
"V体育2025版" Nature · 2012 April 11.
Topological domains in mammalian genomes identified by analysis of chromatin interactions.
-
Nature Genetics · 2007 February 4.
"V体育平台登录" Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.
Support The Ren Lab
To support our work, please click below and specify ‘The Ren Lab’ in the designation field. VSports手机版.